BUY MORE PAY LESS
2000 Item Items
Warning: Last items in stock!
|2||5%||Up to $3.20|
|3||10%||Up to $9.60|
|4||15%||Up to $19.20|
|5||20%||Up to $32.00|
DEPO-MEDROL 40 mg/ml VIAL WITH INJECTABLE SUSPENSION It is administered into the muscle/joint/tendon/lesion.
It contains 40 mg of methylprednisolone acetate in 1 ml vial.
1. What is DEPO-MEDROL and what is it used for?
DEPO-MEDROL is a vial containing methylprednisolone acetate, the active ingredient of which is a corticosteroid. It is marketed in 1 ml vials containing 40 mg of methylprednisolone acetate in each 1 ml.
• Rheumatoid arthritis, calcification (osteoarthritis), inflammation of the sacs around the joint (bursitis), tendon inflammation (tendinitis), inflammation of the muscle tendon sheath (tenosynovitis), chronic inflammation of the protrusion in the joint area called epicondyle (epicondylitis), which causes pain and deformity in the joints, and rheumatic diseases such as inflammation of nerve nodes called ganglia on the tendon,
• A skin disease in the form of rash on the skin due to mental conditions (neurodermitis), a skin disease with thick scaling on the skin (hypertrophic lichen planus), a skin disease with itching on the skin and coin-shaped rashes (nummular eczema), in diabetics skin diseases such as a skin disease that is frequently seen with tissue death (necrobiosis lipoidica diabeticorum), regional hair loss, a disease manifested by scaling on the skin in areas such as the face, neck, nape, shoulders, upper arm (discoid lupus erythematosus), and insect bites,
• Gastrointestinal system diseases such as inflammation of the large intestine (ulcerative colitis), inflammation of the last 10-20 cm of the small intestine (ileum) (Crohn's disease)
Inflammation of tuberculous meningitis (accompanied by appropriate antituberculous chemotherapy)
A congenital disease affecting the formation of adrenal gland hormones (congenital
2. How to use DEPO-MEDROL?
Instructions for proper use and dose/frequency of administration
The dose of DEPO-MEDROL will be adjusted by your doctor according to your response to treatment and your resistance to DEPO-MEDROL.
The dose of the treatment will be determined by your doctor according to the size of the area where the drug will be applied and the disease in which it is used.
Your doctor will tell you how long your treatment with DEPO-MEDROL will last. Early treatment
Do not cut.
In adult patients:
Joints: The amount of dose to be applied to the joint depends on the size of the joint. 20 to 80 mg (0.5 - 2 ml) for large joints (e.g. knee, ankle, shoulder), 10 to 40 mg (0.25 - 1 ml) for medium-sized joints (e.g. elbow and wrist), and small joints (e.g. hand) and the joints of the toes) doses of 4 to 10 mg (0.1 - 0.25 ml) can be administered. For joint injections, it can be applied every week or in a few weeks, depending on the speed of response to treatment.
Inflammation of the sacs around the joint and protrusion in the joint area (bursitis and epicondylitis): Usually the dose is between 4 and 30 mg. (0.1 - 0.75 ml) In most cases there is no need to repeat the injection. In cases that persist for a long time, the injection may need to be repeated.
Skin diseases: Usually the dose is between 20 and 60 mg. (1 -3 ml) It is injected into the affected part of the skin.
For other conditions, a dose of 40 to 120 mg (1 - 3 ml) is injected into the large muscles.
If you are not sure how to use the medicine, consult your doctor or pharmacist.
Application route and method
Depending on the condition being treated and its severity, your doctor may; it will determine the injection site, how much medicine to apply, how much to inject. Your doctor will inject you with the lowest dose as soon as possible to effectively relieve your symptoms.
different age groups
Use in children
Corticosteroids cause growth retardation that may be irreversible in infancy, childhood and adolescence. Treatment should be done at the lowest possible dose and for the shortest period of time. For infants and children, the dosage may be reduced, but children should be monitored based on the clinical situation and the patient's response to therapy.
Use in the elderly
No dosage adjustment is required for the elderly as long as it is used according to the instructions for use. However, in the long-term treatment of elderly patients, it should be kept in mind that the side effects of corticosteroids may cause serious consequences such as osteoporosis, high blood pressure, decrease in blood potassium level, diabetes, susceptibility to infections and thinning of the skin, and close clinical observation may be required.